期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Reversible immortalization of human hepatocytes mediated by retroviral transfer and site-specific recombination 被引量:4
1
作者 Fan-Ying Meng li liu +3 位作者 Feng-Hui Yang chun-you li Jun liu Ping Zhou 《World Journal of Gastroenterology》 SCIE CAS 2014年第36期13119-13126,共8页
AIM: To establish a method for the reversible immortalization of human hepatocytes, which may offer a good and safe source of hepatocytes for practical applications.METHODS: We successfully isolated primary human hepa... AIM: To establish a method for the reversible immortalization of human hepatocytes, which may offer a good and safe source of hepatocytes for practical applications.METHODS: We successfully isolated primary human hepatocytes from surgically resected liver tissue taken from a patient with liver hemangiomas. The freshly isolated cells were then immortalized with retroviral vector SSR#69 expressing simian virus 40 large T antigen(SV40T) and hygromycin-resistance genes flanked by paired loxP recombination targets.RESULTS: The freshly isolated hepatocytes with high viability(85%) were successfully immortalized using retroviral gene transfer of SV40 T. SV40 T in the immortalized cells was then excised by Cre/loxP site-specific recombination. This cell population exhibited the characteristics of differentiated hepatocytes.CONCLUSION: We successfully established reversibly immortalized human hepatocytes, which will provide an unlimited supply of cells for practical applications. 展开更多
关键词 HEPATOCYTE Primary human HEPATOCYTES REVERSIBLE IM
下载PDF
Surgical treatment for uncinate process carcinoma of the pancreas 被引量:1
2
作者 Sen li Yong-Quan Pei +5 位作者 Fu-Tian Du Guan-Yi Zhuang chun-you li Qin-Hua Song Wei Ding Jian-li Wang the Department of Hepatobiliary Surgery, Weifang People’s Hospital, Weifang 261041, China 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2002年第4期592-594,共3页
Objectives: To analyze the clinical features of unci- nate process carcinoma of the pancreas and to im- prove the resection rate. Methods: From January 1990 to June 1999, 10 pa- tients with pancreas uncinate process c... Objectives: To analyze the clinical features of unci- nate process carcinoma of the pancreas and to im- prove the resection rate. Methods: From January 1990 to June 1999, 10 pa- tients with pancreas uncinate process carcinoma re- ceived Whipple's operation. Portal vein (PV) resec- tion and reanastomosis were performed in 5 patients, and the resected length varied from 2.0 to 4.2 cm. Two patients underwent PV lateral wall partial resec- tion. Results: Among the 7 patients undergoing PV resec- tion, 1 died of hepatic failure 3 days after operation. One patient suffered from postoperative chylous asci- tes. These 6 patients survived 13 to 29 months post- operatively. Among the 3 patients without PV resec- tion, 2 survived 13 months and 14 months respective- ly. One patient was alive by the end of follow-up for 11. 5 months postoperatively. Conclusion: Although uncinate process carcinoma of the pancreas has a tendency to invade the adjacent PV and superior mesentery vein, it should not be simply regarded as a contraindication of radical resection. 展开更多
关键词 pancreas neoplasms uncinate process pancreaticoduodenectomy
下载PDF
Hepatocyte isolation from resected benign tissues: Results of a 5-year experience
3
作者 Fan-Ying Meng li liu +5 位作者 Jun liu chun-you li Jian-Ping Wang Feng-Hui Yang Zhi-Shui Chen Ping Zhou 《World Journal of Gastroenterology》 SCIE CAS 2016年第36期8178-8186,共9页
AIM To analyze retrospectively a 5-year experience of human hepatocyte isolation from resected liver tissues with benign disease.METHODS We established a method of modified four-step retrograde perfusion to isolate pr... AIM To analyze retrospectively a 5-year experience of human hepatocyte isolation from resected liver tissues with benign disease.METHODS We established a method of modified four-step retrograde perfusion to isolate primary human hepatocytes. Samples were collected from the resected livers of patients with intrahepatic duct calculi(n = 7) and liver hemangioma(n = 17). Only the samples weighing ≥ 15 g were considered suitable for hepatocyte isolation. By using the standard trypan blue exclusion technique, hepatocyte viability and yield were immediately determined after isolation.RESULTS Twenty-four liver specimens, weighing 15-42 g, were immediately taken from the margin of the removed samples and transferred to the laboratory for hepatocyte isolation. Warm ischemia time was 5-35 min and cold ischemia time was 15-45 min. For the 7 samples of intrahepatic duct calculi, the method resulted in a hepatocyte yield of 3.49 ± 2.31 × 10~6 hepatocytes/g liver, with 76.4% ± 10.7% viability. The 17 samples of liver hemangioma had significantly higher yield of cells(5.4 ± 1.71 × 10~6 cells/g vs 3.49 ± 2.31 × 10~6 cells/g, P < 0.05) than the samples of intrahepatic duct calculi. However, there seems to be no clear difference in cell viability(80.3% ± 9.67% vs 76.4% ± 10.7%, P > 0.05). We obtained a cell yield of 5.31 ± 1.87 × 10~6 hepatocytes/g liver when the samples weighed > 20 g. However, for the tissues weighing ≤ 20 g, a reduction in yield was found(3.08 ± 1.86 × 10~6 cells/g vs 5.31 ± 1.87 × 10~6 cells/g, P < 0.05).CONCLUSION Benign diseased livers are valuable sources for largenumber hepatocyte isolation. Our study represents the largest number of primary human hepatocytes isolated from resected specimens from patients with benign liver disease. We evaluated the effect of donor liver characteristics on cell isolation, and we found that samples of liver hemangioma can provide better results than intrahepatic duct calculi, in terms of cell yield. Furthermore, the size of the tissues can affect the outcome of hepatocyte isolation. 展开更多
关键词 Human HEPATOCYTE PRIMARY HEPATOCYTE Cell ISOLATION BENIGN liver disease HEPATOCYTE ISOLATION
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部